Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

IL-13 from Th2-type cells suppresses induction of antigen-specific Th1 immunity in a T-cell lymphoma.

Deepak P, Kumar S Jr, Kishore D, Acharya A.

Int Immunol. 2010 Jan;22(1):53-63. doi: 10.1093/intimm/dxp114. Epub 2009 Nov 30.

PMID:
19951958
2.

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.

Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hätscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C.

N Engl J Med. 2009 Nov 19;361(21):2033-45. doi: 10.1056/NEJMoa0907206. Epub 2009 Nov 4.

3.

Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.

He R, Kim HY, Yoon J, Oyoshi MK, MacGinnitie A, Goya S, Freyschmidt EJ, Bryce P, McKenzie AN, Umetsu DT, Oettgen HC, Geha RS.

J Allergy Clin Immunol. 2009 Oct;124(4):761-70.e1. doi: 10.1016/j.jaci.2009.07.040.

4.

Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease.

Sakuraba A, Sato T, Kamada N, Kitazume M, Sugita A, Hibi T.

Gastroenterology. 2009 Nov;137(5):1736-45. doi: 10.1053/j.gastro.2009.07.049. Epub 2009 Jul 24.

PMID:
19632232
6.

A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production.

Newcomb DC, Zhou W, Moore ML, Goleniewska K, Hershey GK, Kolls JK, Peebles RS Jr.

J Immunol. 2009 May 1;182(9):5317-21. doi: 10.4049/jimmunol.0803868.

7.

Regulatory lymphocytes and intestinal inflammation.

Izcue A, Coombes JL, Powrie F.

Annu Rev Immunol. 2009;27:313-38. doi: 10.1146/annurev.immunol.021908.132657. Review.

PMID:
19302043
8.

Defective IL-10 production in severe phenotypes of Crohn's disease.

Correa I, Veny M, Esteller M, Piqué JM, Yagüe J, Panés J, Salas A.

J Leukoc Biol. 2009 May;85(5):896-903. doi: 10.1189/jlb.1108698. Epub 2009 Feb 23.

PMID:
19237638
9.

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA.

Immunity. 2008 Dec 19;29(6):947-57. doi: 10.1016/j.immuni.2008.11.003.

10.

The role of IL-13 and NK T cells in experimental and human ulcerative colitis.

Fuss IJ, Strober W.

Mucosal Immunol. 2008 Nov;1 Suppl 1:S31-3. doi: 10.1038/mi.2008.40. Review.

11.

The intestinal epithelium: sensors to effectors in nematode infection.

Artis D, Grencis RK.

Mucosal Immunol. 2008 Jul;1(4):252-64. doi: 10.1038/mi.2008.21. Epub 2008 May 13. Review.

PMID:
19079187
12.

Diminution of Circulating CD4+CD25 high T cells in naïve Crohn's disease.

Chamouard P, Monneaux F, Richert Z, Voegeli AC, Lavaux T, Gaub MP, Baumann R, Oudet P, Muller S.

Dig Dis Sci. 2009 Oct;54(10):2084-93. doi: 10.1007/s10620-008-0590-6. Epub 2008 Dec 3.

PMID:
19051021
13.

IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis.

Fichtner-Feigl S, Young CA, Kitani A, Geissler EK, Schlitt HJ, Strober W.

Gastroenterology. 2008 Dec;135(6):2003-13, 2013.e1-7. doi: 10.1053/j.gastro.2008.08.055. Epub 2008 Sep 11.

PMID:
18938165
14.

Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.

Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, Domingues FS, Albrecht M, Nothnagel M, Ellinghaus D, Sina C, Onnie CM, Weersma RK, Stokkers PC, Wijmenga C, Gazouli M, Strachan D, McArdle WL, Vermeire S, Rutgeerts P, Rosenstiel P, Krawczak M, Vatn MH; IBSEN study group, Mathew CG, Schreiber S.

Nat Genet. 2008 Nov;40(11):1319-23. doi: 10.1038/ng.221. Epub 2008 Oct 5.

PMID:
18836448
15.

Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production.

Elliott DE, Metwali A, Leung J, Setiawan T, Blum AM, Ince MN, Bazzone LE, Stadecker MJ, Urban JF Jr, Weinstock JV.

J Immunol. 2008 Aug 15;181(4):2414-9.

16.

Role of cytokines in inflammatory bowel disease.

Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK.

World J Gastroenterol. 2008 Jul 21;14(27):4280-8. Review.

17.

Negative regulation of Th17 responses.

Stumhofer JS, Silver J, Hunter CA.

Semin Immunol. 2007 Dec;19(6):394-9. doi: 10.1016/j.smim.2007.11.006. Epub 2008 Jan 24. Review.

18.

Innate and adaptive mechanisms to control [corrected] pathological intestinal inflammation.

Kelsall BL.

J Pathol. 2008 Jan;214(2):242-59. Review. Erratum in: J Pathol. 2008 Aug;215(4):457.

PMID:
18161750
19.

Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain.

Ramalingam TR, Pesce JT, Sheikh F, Cheever AW, Mentink-Kane MM, Wilson MS, Stevens S, Valenzuela DM, Murphy AJ, Yancopoulos GD, Urban JF Jr, Donnelly RP, Wynn TA.

Nat Immunol. 2008 Jan;9(1):25-33. Epub 2007 Dec 9.

20.

IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice.

Wilson MS, Elnekave E, Mentink-Kane MM, Hodges MG, Pesce JT, Ramalingam TR, Thompson RW, Kamanaka M, Flavell RA, Keane-Myers A, Cheever AW, Wynn TA.

J Clin Invest. 2007 Oct;117(10):2941-51.

Supplemental Content

Support Center